New hope for women with Tough-to-Treat cervical cancer
NCT ID NCT07392060
Summary
This study is testing whether a new drug combination (WX390 plus toripalimab) works better than standard treatments for women with advanced cervical cancer that has returned or spread after previous platinum-based therapy. The trial will involve 440 participants across multiple centers and will primarily measure whether the new combination helps patients live longer. This is a Phase 3 study, meaning it's a large-scale test to see if the treatment should become widely available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.